{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:19:10Z","timestamp":1790900350400,"version":"4.1.0"},"reference-count":63,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T00:00:00Z","timestamp":1547596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0209605","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T18:45:52Z","timestamp":1547664352000},"page":"e0209605","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":43,"title":["Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6139-9199","authenticated-orcid":true,"given":"Patrycja","family":"Machnowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolin","family":"Meixenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8205-4755","authenticated-orcid":true,"given":"Daniel","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Jessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heribert","family":"Hillenbrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Gunsenheimer-Bartmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamah","family":"Hamouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"K\u00fccherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Bannert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the German HIV-1 Seroconverter Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,1,16]]},"reference":[{"key":"ref1","unstructured":"WHO. HIV\/AIDS\u2014Fact sheet 2017."},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00002030-200401230-00012","article-title":"Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy","volume":"18","author":"M Violin","year":"2004","journal-title":"AIDS"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/01.aids.0000174455.01369.ad","article-title":"Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients","volume":"19","author":"M Zaccarelli","year":"2005","journal-title":"Aids"},{"issue":"3","key":"ref4","first-page":"68","article-title":"Frequency of drug-resistant variants of HIV-1 coexistent with wild-type in treatment-naive patients of India","volume":"7","author":"N Sachdeva","year":"2005","journal-title":"MedGenMed"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1128\/JVI.02712-06","article-title":"The fitness cost of mutations associated with human immunodeficiency virus type 1 drug resistance is modulated by mutational interactions","volume":"81","author":"ME Cong","year":"2007","journal-title":"J Virol"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1128\/JVI.73.5.3744-3752.1999","article-title":"Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1","volume":"73","author":"J Martinez-Picado","year":"1999","journal-title":"J Virol"},{"issue":"16","key":"ref7","doi-asserted-by":"crossref","first-page":"9268","DOI":"10.1128\/JVI.00695-14","article-title":"Altered viral fitness and drug susceptibility in HIV-1 carrying mutations that confer resistance to nonnucleoside reverse transcriptase and integrase strand transfer inhibitors","volume":"88","author":"Z Hu","year":"2014","journal-title":"J Virol"},{"key":"ref8","article-title":"Antiretroviral Resistance in Clinical Practice","author":"A De Luca","year":"2006"},{"issue":"7","key":"ref9","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/jac\/dkr157","article-title":"Evolutionary pathways of transmitted drug-resistant HIV-1","volume":"66","author":"M Pingen","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"e4724","DOI":"10.1371\/journal.pone.0004724","article-title":"Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update","volume":"4","author":"DE Bennett","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/nar\/gkg100","article-title":"Human immunodeficiency virus reverse transcriptase and protease sequence database","volume":"31","author":"SY Rhee","year":"2003","journal-title":"Nucleic Acids Res"},{"issue":"Suppl 1","key":"ref12","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1086\/505356","article-title":"Rationale and uses of a public HIV drug-resistance database","volume":"194","author":"RW Shafer","year":"2006","journal-title":"J Infect Dis"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ijid.2008.10.008","article-title":"Understanding transmitted HIV resistance through the experience in the USA","volume":"13","author":"B Taiwo","year":"2009","journal-title":"Int J Infect Dis"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1128\/JVI.02579-07","article-title":"Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection","volume":"82","author":"SJ Little","year":"2008","journal-title":"J Virol"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/infdis\/jit345","article-title":"Persistence of HIV-1 transmitted drug resistance mutations","volume":"208","author":"H Castro","year":"2013","journal-title":"J Infect Dis"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/infdis\/jiq167","article-title":"Differential persistence of transmitted HIV-1 drug resistance mutation classes","volume":"203","author":"V Jain","year":"2011","journal-title":"J Infect Dis"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"e1004722","DOI":"10.1371\/journal.ppat.1004722","article-title":"Persistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgrounds","volume":"11","author":"WL Yang","year":"2015","journal-title":"PLoS Pathog"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/QAI.0000000000001122","article-title":"Inferring HIV-1 Transmission Dynamics in Germany From Recently Transmitted Viruses","volume":"73","author":"K Pouran Yousef","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.2.30436","article-title":"National molecular surveillance of recently acquired HIV infections in Germany, 2013 to 2014","volume":"22","author":"A Hauser","year":"2017","journal-title":"Euro Surveill"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/infdis\/jiv008","article-title":"Interplay Between Transmitted and Acquired HIV Type 1 Drug Resistance: Reasons for a Disconnect","volume":"212","author":"A De Luca","year":"2015","journal-title":"J Infect Dis"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1086\/597352","article-title":"Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland","volume":"48","author":"V von Wyl","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"e0172473","DOI":"10.1371\/journal.pone.0172473","article-title":"Expanding HIV-1 subtype B transmission networks among men who have sex with men in Poland","volume":"12","author":"M Parczewski","year":"2017","journal-title":"PLoS One"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"e0206234","DOI":"10.1371\/journal.pone.0206234","article-title":"Increasing proportions of HIV-1 non-B subtypes and of NNRTI resistance between 2013 and 2016 in Germany: Results from the national molecular surveillance of new HIV-diagnoses","volume":"13","author":"A Hauser","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"e95956","DOI":"10.1371\/journal.pone.0095956","article-title":"First line treatment response in patients with transmitted HIV drug resistance and well defined time point of HIV infection: updated results from the German HIV-1 seroconverter study","volume":"9","author":"F Zu Knyphausen","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012718","article-title":"Prevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort","volume":"5","author":"B Bartmeyer","year":"2010","journal-title":"Plos One"},{"issue":"1\u20132","key":"ref26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1386-6532(99)00010-4","article-title":"Rapid, phenotypic HIV-1 drug sensitivity assay for protease and reverse transcriptase inhibitors","volume":"13","author":"H Walter","year":"1999","journal-title":"J Clin Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.meegid.2013.04.032","article-title":"Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools","volume":"19","author":"AC Pineda-Pena","year":"2013","journal-title":"Infect Genet Evol"},{"issue":"8","key":"ref28","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1128\/JCM.03289-13","article-title":"Assessment of ambiguous base calls in HIV-1 pol population sequences as a biomarker for identification of recent infections in HIV-1 incidence studies","volume":"52","author":"K Meixenberger","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/molbev\/msu300","article-title":"IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies","volume":"32","author":"LT Nguyen","year":"2015","journal-title":"Mol Biol Evol"},{"key":"ref30","unstructured":"EACS. European AIDS Clinical Society (EACS) guidelines Version 9.0. October 2017."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1186\/s12879-015-1217-0","article-title":"Characteristics and spread to the native population of HIV-1 non-B subtypes in two European countries with high migration rate","volume":"15","author":"K Dauwe","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"9","key":"ref32","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/infdis\/jiv758","article-title":"Transmission of Non-B HIV Subtypes in the United Kingdom Is Increasingly Driven by Large Non-Heterosexual Transmission Clusters","volume":"213","author":"M Ragonnet-Cronin","year":"2016","journal-title":"J Infect Dis"},{"issue":"7","key":"ref33","doi-asserted-by":"crossref","first-page":"e101738","DOI":"10.1371\/journal.pone.0101738","article-title":"Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic","volume":"9","author":"AC Pineda-Pena","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/infdis\/jiv012","article-title":"Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012","volume":"212","author":"WL Yang","year":"2015","journal-title":"J Infect Dis"},{"issue":"15","key":"ref35","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1097\/QAD.0000000000000768","article-title":"A phylotype-based analysis highlights the role of drug-naive HIV-positive individuals in the transmission of antiretroviral resistance in the UK","volume":"29","author":"R Mourad","year":"2015","journal-title":"AIDS"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/jac\/dku372","article-title":"Transmitted HIV drug resistance in antiretroviral-treatment-naive patients from Poland differs by transmission category and subtype","volume":"70","author":"M Parczewski","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"e0125837","DOI":"10.1371\/journal.pone.0125837","article-title":"Trends in Transmission of Drug Resistance and Prevalence of Non-B Subtypes in Patients with Acute or Recent HIV-1 Infection in Barcelona in the Last 16 Years (1997\u20132012)","volume":"10","author":"J Ambrosioni","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"ref38","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1086\/644505","article-title":"Transmission of drug-resistant HIV-1 is stabilizing in Europe","volume":"200","author":"J Vercauteren","year":"2009","journal-title":"J Infect Dis"},{"issue":"5","key":"ref39","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/QAD.0b013e3282f5e062","article-title":"Transmission of drug-resistant HIV-1 in Europe remains limited to single classes","volume":"22","year":"2008","journal-title":"AIDS"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/1471-2334-14-407","article-title":"Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe","volume":"14","author":"D Frentz","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/cid\/civ963","article-title":"Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe","volume":"62","author":"LM Hofstra","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/QAD.0000000000001689","article-title":"Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort","volume":"32","author":"A Olson","year":"2018","journal-title":"AIDS"},{"issue":"8","key":"ref43","doi-asserted-by":"crossref","first-page":"e104474","DOI":"10.1371\/journal.pone.0104474","article-title":"Estimating trends in the proportion of transmitted and acquired HIV drug resistance in a long term observational cohort in Germany","volume":"9","author":"D Schmidt","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cit694","article-title":"Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study","volume":"58","author":"SM Drescher","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.meegid.2017.07.003","article-title":"Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003\u20132015: Transmitted drug resistance is due to onward transmissions","volume":"54","author":"D Paraskevis","year":"2017","journal-title":"Infect Genet Evol"},{"issue":"11","key":"ref46","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1097\/QAD.0b013e32832d40ad","article-title":"The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection","volume":"23","author":"S Yerly","year":"2009","journal-title":"AIDS"},{"issue":"2","key":"ref47","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/QAD.0b013e328333ddee","article-title":"Transmission networks of HIV-1 among men having sex with men in the Netherlands","volume":"24","author":"D Bezemer","year":"2010","journal-title":"AIDS"},{"issue":"7","key":"ref48","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1086\/512088","article-title":"High rates of forward transmission events after acute\/early HIV-1 infection","volume":"195","author":"BG Brenner","year":"2007","journal-title":"J Infect Dis"},{"issue":"3","key":"ref49","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1371\/journal.pmed.0050050","article-title":"Episodic sexual transmission of HIV revealed by molecular phylodynamics","volume":"5","author":"F Lewis","year":"2008","journal-title":"PLoS Med"},{"key":"ref50","unstructured":"Schmidt D, Kollan C, Bremer V, Gunsenheimer-Bartmeyer B, Group obotCHS. Persistent viremia\u2014Is this still an ongoing problem in antiretroviral treatment in Germany? 16th European Aids Conference (EACS) 2017 Milan, Italy. 2017."},{"key":"ref51","first-page":"531","article-title":"Sch\u00e4tzung der Zahl der HIV-Neuinfektionen und der Gesamtzahl von Menschen mit HIV in Deutschland, Stand Ende 2016","volume":"47","author":"M an der Heiden","year":"2017","journal-title":"Epid Bull"},{"key":"ref52","unstructured":"Hauser A, Hofmann A, Meixenberger K, Altmann B, Hanke K, Fiedler S, et al. Prevalence of resistance to integrase inhibitors in newly diagnosed HIV cases: results from the national molecular surveillance, Germany 2014\u20132017. 16th European Meeting on HIV & Hepatitis 2018, Rome, Italy, P27. 2018."},{"issue":"45","key":"ref53","doi-asserted-by":"crossref","first-page":"38110","DOI":"10.1074\/jbc.M112.398180","article-title":"Biochemical mechanism of HIV-1 resistance to rilpivirine","volume":"287","author":"K Singh","year":"2012","journal-title":"J Biol Chem"},{"issue":"1","key":"ref54","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/QAI.0b013e31823df4da","article-title":"Genotypic and phenotypic characterization of HIV-1 isolates obtained from patients on rilpivirine therapy experiencing virologic failure in the phase 3 ECHO and THRIVE studies: 48-week analysis","volume":"59","author":"L Rimsky","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"ref55","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1128\/AAC.00348-13","article-title":"Effect of mutations at position E138 in HIV-1 reverse transcriptase and their interactions with the M184I mutation on defining patterns of resistance to nonnucleoside reverse transcriptase inhibitors rilpivirine and etravirine","volume":"57","author":"HT Xu","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"ref56","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1128\/AAC.01029-13","article-title":"Basis for Early and Preferential Selection of the E138K Mutation in HIV-1 Reverse Transcriptase","volume":"57","author":"M McCallum","year":"2013","journal-title":"Antimicrob Agents Ch"},{"issue":"1","key":"ref57","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/JCM.43.1.406-413.2005","article-title":"Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis","volume":"43","author":"S Palmer","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"1","key":"ref58","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jac\/dkw404","article-title":"Enhanced surveillance of HIV-1 drug resistance in recently infected MSM in the UK","volume":"72","author":"E Cunningham","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"ref59","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1128\/AAC.01494-08","article-title":"Detection of human immunodeficiency virus (HIV) type 1 M184V and K103N minority variants in patients with primary HIV infection","volume":"53","author":"TA Toni","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"ref60","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1093\/jac\/dkr354","article-title":"'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing","volume":"66","author":"C Alteri","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"ref61","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1468-1293.2012.01037.x","article-title":"Deep sequencing does not reveal additional transmitted mutations in patients diagnosed with HIV-1 variants with single nucleoside reverse transcriptase inhibitor resistance mutations","volume":"14","author":"M Pingen","year":"2013","journal-title":"HIV Med"},{"issue":"3","key":"ref62","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/infdis\/jix338","article-title":"Prevalence of Drug-Resistant Minority Variants in Untreated HIV-1-Infected Individuals With and Those Without Transmitted Drug Resistance Detected by Sanger Sequencing","volume":"216","author":"DS Clutter","year":"2017","journal-title":"J Infect Dis"},{"issue":"suppl_9","key":"ref63","doi-asserted-by":"crossref","first-page":"S847","DOI":"10.1093\/infdis\/jix430","article-title":"The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure","volume":"216","author":"N Stella-Ascariz","year":"2017","journal-title":"J Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0209605","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T11:52:43Z","timestamp":1662810763000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0209605"}},"subtitle":[],"editor":[{"given":"Orna","family":"Mor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,16]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0209605","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,16]]}}}